AI Agentic Patient Support Program (PSP)

Patient support. Reimagined.

A new generation of patient support, organized as a connected ecosystem – an agentic layer that orchestrates proactive support based on approved content and easier routing to human support, with compliance and human oversight across the whole service.

Designed to deliver greater availability, deeper personalization, and faster responsiveness for patients, within a more scalable, affordable delivery model for pharmaceutical companies.

Built on the Dawn Platform, powered by Microsoft and NVIDIA technologies.

A patient’s journey doesn’t end when an appointment does

People living with chronic diseases are faced with the difficult reality of continuing to live their everyday lives while keeping up with their treatments and care.

The episodic nature and limited resources of the existing healthcare ecosystem result in people living with these conditions oftentimes feeling alone and struggling to access relevant support in the moments of true need.  

Pharmaceutical companies have tried to alleviate some of these needs through their Patient Support Programs (PSPs), however they are struggling to overcome the current challenges of a fragmented, reactive, and difficult to scale model.
‍
This moment in time represents an opportunity to create more connected and personalized support that is responsive in the exact moments of need, while enabling easier scaling across the full patient population and ensuring integration into the wider healthcare ecosystem.

Introducing Dawn Health’s AI Agentic PSP

An AI agentic care experience available to patients 24/7, based on a deep understanding of each patient's individual context and state, with fully personalized support and access to human support when desired.

Diagram showing interaction between Patient and PSP Nurse linked by arrows, with a central box labeled Dawn Companion containing an Agentic Layer above and a Compliance Gate below connected by bidirectional arrows.

*approved content and market rules, checked before anything reaches the patient.

The agentic engagement is anchored in each patient’s context and state, which builds over time across interactions, tracked insights and data, treatment schedule, and individual needs.

With that, the agentic engagement handles daily/routine interactions, while human PSP nurses can be reached out to in moments of true need. Care teams become more available to quickly respond to patients’ needs, while continuing to provide the human-centered, empathetic support they are known for.

Compliance and human oversight are built in by design across the whole solution, including market-specific rules before anything reaches a patient, as well as the predefined rules for escalation.  

Scale patient support more cost-effectively

Significantly lower costs to serve

By supporting routine patient interactions and streamlining administrative workflows, Dawn Health’s AI Agentic PSP aims to extend routine patient support while enabling nurses and care teams to focus on moments that require human expertise.

Our vision

For Patients

  • Availability 24/7  
  • Personalized conversations grounded in approved information
  • Proactive support that takes lived experience and individual context into account
  • Easier routing to PSP nurses when desired by patients

For Pharma Companies

  • More impactful service offering to patients, enabling them to better access and manage their treatment and care
  • Extends the reach and responsiveness of support, complementing the care patients receive from their healthcare team
  • Enterprise-readiness by design to bring the same support to as many patients as quickly as possible

Four organizations, one shared ambition

Dawn Health is collaborating with Merck, NVIDIA and Microsoft to explore and advance a new approach to patient support, bringing together expertise in digital health, patient needs, AI and cloud technologies.  

Merck has signed on as an early innovation partner to bring this patient support service into rare tumors, specifically Desmoid & NF-1 tumors.

  • Dawn Health: Digital Health Product Development and the Dawn Platform.  
  • Merck: Therapeutic expertise and understanding of patient needs.  
  • NVIDIA: Advanced AI technology.  
  • Microsoft: Cloud and AI technologies.  

“Brilliant partnership to bring a scalable approach to improve patient support in rare tumours. Looking forward to hearing about implementation and scale of this ambitious programme.”

Healthcare industry leader  

“The most meaningful advances in healthcare happen when we bring different expertise together around one common goal: improving patients’ lives.”

Healthcare professional     

“This is a meaningful example of technology supporting people through a difficult care journey.”

Technology & AI commentator (excerpt)

Explore the vision with our team

Johannes

Johannes Boshkow

Head of Partnerships at Dawn Health

LinkedIn
Explore cases

DHDK_WEB_DragonCopilot_01_V0